Search

Each record is a registered study, a systematic-review registration or a publication. A registered or ongoing study is not a finding, and animal or cell research does not show an effect in people. The same study can appear under more than one subject, so the number of records is not a count of independent studies. You can also search an exact DOI, PubMed ID, NCT or CRD number. How to read these records.

35 study records (showing up to 30 per record type)

• Registered trial NCT06008223 Completed (results not assessed here)
  Clinical Analysis of Vitamin B6 in Sepsis
  Condition or outcome area: Sepsis|Vitamin B6|Kidney Injury|Inflammatory Response|Oxidative Stress Response
  2021-11-01 · Subject: Vitamin B6; Pyridoxal 5'-phosphate(2-); BSPBio_000586; Pyridoxol; CJ-24195; Oprea1_061614; CHEBI:597326; 2-methyl-4,5-dimethylol-pyridin-3-ol; 2-Picoline-4,5-dimethanol, 3-hydroxy-; Prestwick3_000623 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT05449171 Completed (results not assessed here)
  High Molecular Weight Hyaluronic Acid, α-lipoic Acid, Magnesium, Vitamin B6 and Vitamin D, in the Prevention of Spontaneous Abortion
  Condition or outcome area: Abortion, Spontaneous
  2022-09-01 · Subject: Vitamin D; 24,25-Dihydroxyvitamin D; (6R)-6-[(1R,3aS,4E,7aR)-4-{2-[(1Z,5R)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene}-7a-methyl-octahydro-1H-inden-1-yl]-2-methylheptane-2,3-diol; CHEBI:89324; 24,25-dihydroxyvitamin; 24,25-Dihydroxycholecalciferol; 24,25-dihydroxyvitamin D3; (3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-3,24,25-triol · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT04874662 Completed (results not assessed here)
  Nicotinamide (NAM) and Pyridoxine (Vitamin B6) on Muscle Regeneration ("Satellite-01 Study").
  Condition or outcome area: Muscle Injury
  2021-05-03 · Subject: Vitamin B6; Pyridoxal 5'-phosphate(2-); BSPBio_000586; Pyridoxol; CJ-24195; Oprea1_061614; CHEBI:597326; 2-methyl-4,5-dimethylol-pyridin-3-ol; 2-Picoline-4,5-dimethanol, 3-hydroxy-; Prestwick3_000623 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00659269 Phase 3 Completed (results not assessed here)
  A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients
  Condition or outcome area: Cancer
  2006-07 · Subject: Vitamin B6; Pyridoxal 5'-phosphate(2-); BSPBio_000586; Pyridoxol; CJ-24195; Oprea1_061614; CHEBI:597326; 2-methyl-4,5-dimethylol-pyridin-3-ol; 2-Picoline-4,5-dimethanol, 3-hydroxy-; Prestwick3_000623 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT04509401 Completed (results not assessed here)
  Effects of High Dose of Vitamin B6 With Magnesium in Children With Autism Spectrum Disorder
  Condition or outcome area: ASD
  2020-01-11 · Subject: Vitamin B6; Pyridoxal 5'-phosphate(2-); BSPBio_000586; Pyridoxol; CJ-24195; Oprea1_061614; CHEBI:597326; 2-methyl-4,5-dimethylol-pyridin-3-ol; 2-Picoline-4,5-dimethanol, 3-hydroxy-; Prestwick3_000623 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT04070391 Completed (results not assessed here)
  Vitamin B6 Supplementation and Mood States in College Women Taking Oral Contraceptives
  Condition or outcome area: Depression
  2019-01-01 · Subject: Vitamin B6; Pyridoxal 5'-phosphate(2-); BSPBio_000586; Pyridoxol; CJ-24195; Oprea1_061614; CHEBI:597326; 2-methyl-4,5-dimethylol-pyridin-3-ol; 2-Picoline-4,5-dimethanol, 3-hydroxy-; Prestwick3_000623 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT03580499 Not completed: Active Not Recruiting
  Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen Therapy
  Condition or outcome area: Hot Flashes|Prostate Carcinoma
  2018-09-13 · Subject: Vitamin B6; Pyridoxal 5'-phosphate(2-); BSPBio_000586; Pyridoxol; CJ-24195; Oprea1_061614; CHEBI:597326; 2-methyl-4,5-dimethylol-pyridin-3-ol; 2-Picoline-4,5-dimethanol, 3-hydroxy-; Prestwick3_000623 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT02625415 Completed (results not assessed here)
  The Topical Application of Vitamin B6 in Palmar-Plantar Erythrodysesthesia
  Condition or outcome area: Palmar-Plantar Erythrodysesthesia
  2016-07 · Subject: Vitamin B6; Pyridoxal 5'-phosphate(2-); BSPBio_000586; Pyridoxol; CJ-24195; Oprea1_061614; CHEBI:597326; 2-methyl-4,5-dimethylol-pyridin-3-ol; 2-Picoline-4,5-dimethanol, 3-hydroxy-; Prestwick3_000623 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT01128244 Phase 2 / Phase 3 Completed (results not assessed here)
  Vitamin B6 Effects for Women Taking Birth Control Pills
  Condition or outcome area: Vitamin B6 Deficiency
  2010-04 · Subject: Vitamin B6; Pyridoxal 5'-phosphate(2-); BSPBio_000586; Pyridoxol; CJ-24195; Oprea1_061614; CHEBI:597326; 2-methyl-4,5-dimethylol-pyridin-3-ol; 2-Picoline-4,5-dimethanol, 3-hydroxy-; Prestwick3_000623 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00693589 Phase 2 Completed (results not assessed here)
  Effect of Homocysteine-Lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Endothelium-Dependent Vasodilatation of Forearm Resistance Vessels in Patients With Coronary Heart Disease
  Condition or outcome area: Cardiovascular Disease|Endothelial Dysfunction
  2005-01 · Subject: Vitamin B6; Pyridoxal 5'-phosphate(2-); BSPBio_000586; Pyridoxol; CJ-24195; Oprea1_061614; CHEBI:597326; 2-methyl-4,5-dimethylol-pyridin-3-ol; 2-Picoline-4,5-dimethanol, 3-hydroxy-; Prestwick3_000623 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00693589 Phase 2 Completed (results not assessed here)
  Effect of Homocysteine-Lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Endothelium-Dependent Vasodilatation of Forearm Resistance Vessels in Patients With Coronary Heart Disease
  Condition or outcome area: Cardiovascular Disease|Endothelial Dysfunction
  2005-01 · Subject: Vitamin B12; Cyanocobalamin;Cyanocob(III)alamin · open the ingredient record · ClinicalTrials.gov
• Systematic review registration CRD42023421930 Registered protocol, no results here: Review Ongoing
  B vitamins and risk of coronary heart disease: a systematic review and meta-analysis
  Condition or outcome area: Coronary heart disease is one of the major cardiovascular diseases threatening human health, with 11 million people suffering from coronary heart disease in China. The early stage of coronary heart disease is usually asymptomatic. Some patients may have symptoms of angina pectoris after strenuous activities. In severe cases, patients may have a sense of chest pressure, shortness of breath, and feel very tired. B vitamins, for their effectiveness in preventing coronary heart disease, have been st
  2023-05-08 · Subject: Vitamin b6; Pyridoxal 5'-phosphate(2-); pyridoxal 5'-phosphate(2-); (4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl phosphate; 124051-94-1; pyridoxal 5'-phosphate dianion; CHEBI:597326; Q27225781; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate dianion; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate(2-) · open the ingredient record
• Systematic review registration CRD42022384203 Registered protocol, no results here: Review Ongoing
  Efficacy of four antiemetic drugs (doxylamine alone, pyridoxine (vitamin B6) alone, association doxylamine/pyridoxine, metoclopramide alone) for the treatment of nausea or vomiting of pregnancy : a systematic review of literature and meta-analysis of randomized controlled trials.
  Condition or outcome area: Nausea and vomiting of pregnancy
  2022-12-25 · Subject: Vitamin b6; Pyridoxal 5'-phosphate(2-); pyridoxal 5'-phosphate(2-); (4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl phosphate; 124051-94-1; pyridoxal 5'-phosphate dianion; CHEBI:597326; Q27225781; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate dianion; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate(2-) · open the ingredient record
• Systematic review registration CRD42022384203 Registered protocol, no results here: Review Ongoing
  Efficacy of four antiemetic drugs (doxylamine alone, pyridoxine (vitamin B6) alone, association doxylamine/pyridoxine, metoclopramide alone) for the treatment of nausea or vomiting of pregnancy : a systematic review of literature and meta-analysis of randomized controlled trials.
  Condition or outcome area: Nausea and vomiting of pregnancy
  2022-12-25 · Subject: Vitaminｂ · open the ingredient record
• Systematic review registration CRD42022355077 Registered protocol, no results here: Review Ongoing
  Efficacy of folic acid supplementation in combination with vitamin B12 and vitamin B6 for stroke prevention: a meta-analysis
  Condition or outcome area: Stroke is one of the major public health problems and a leading cause of death and disability among adults worldwide. Recent studies show that the number of people affected by stroke reached 101 million and disability-adjusted life years (DALYs) reached 143 million worldwide in 2019, creating a significant disease and economic burden.
  2022-09-01 · Subject: Vitamin b6; Pyridoxal 5'-phosphate(2-); pyridoxal 5'-phosphate(2-); (4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl phosphate; 124051-94-1; pyridoxal 5'-phosphate dianion; CHEBI:597326; Q27225781; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate dianion; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate(2-) · open the ingredient record
• Systematic review registration CRD42022355077 Registered protocol, no results here: Review Ongoing
  Efficacy of folic acid supplementation in combination with vitamin B12 and vitamin B6 for stroke prevention: a meta-analysis
  Condition or outcome area: Stroke is one of the major public health problems and a leading cause of death and disability among adults worldwide. Recent studies show that the number of people affected by stroke reached 101 million and disability-adjusted life years (DALYs) reached 143 million worldwide in 2019, creating a significant disease and economic burden.
  2022-09-01 · Subject: Vitamin b12; vitamin B12; cyanocobalamin; 68-19-9; Cyanocob(III)alamin; DTXCID5024346; MFCD00151092; Cobalamin (1+); Cyanocobalamin;Cyanocob(III)alamin; CAS-68-19-9 · open the ingredient record
• Systematic review registration CRD42022352776 Registered protocol, no results here: Review Ongoing
  Association between vitamin B6 and the risk of colorectal cancer: a systemic review and meta-analysis
  Condition or outcome area: Colorectal cancer, currently the third most common cancer in the world, imposes a severe burden on the world's health system. Researchers around the world are currently looking for ways to prevent colorectal cancer. Vitamin B6 is a common vitamin in our life and exists in a variety of daily foods. Pyridoxine 5-phosphate (PLP) is the main active coenzyme form of vitamin B6 and is involved in nearly 100 enzymatic reactions. Therefore, low vitamin B6 levels may increase the risk of colorectal cance
  2022-08-22 · Subject: Vitamin b6; Pyridoxal 5'-phosphate(2-); pyridoxal 5'-phosphate(2-); (4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl phosphate; 124051-94-1; pyridoxal 5'-phosphate dianion; CHEBI:597326; Q27225781; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate dianion; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate(2-) · open the ingredient record
• Systematic review registration CRD42022352776 Registered protocol, no results here: Review Ongoing
  Association between vitamin B6 and the risk of colorectal cancer: a systemic review and meta-analysis
  Condition or outcome area: Colorectal cancer, currently the third most common cancer in the world, imposes a severe burden on the world's health system. Researchers around the world are currently looking for ways to prevent colorectal cancer. Vitamin B6 is a common vitamin in our life and exists in a variety of daily foods. Pyridoxine 5-phosphate (PLP) is the main active coenzyme form of vitamin B6 and is involved in nearly 100 enzymatic reactions. Therefore, low vitamin B6 levels may increase the risk of colorectal cance
  2022-08-22 · Subject: Vitaminｂ · open the ingredient record
• Systematic review registration CRD42022212316 Registered protocol, no results here: Review Ongoing
  A systematic review of the potential role of abnormal vitamin B6 levels in patients with Parkinson's disease
  Condition or outcome area: Parkinson's disease
  2022-05-20 · Subject: Vitamin b6; Pyridoxal 5'-phosphate(2-); pyridoxal 5'-phosphate(2-); (4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl phosphate; 124051-94-1; pyridoxal 5'-phosphate dianion; CHEBI:597326; Q27225781; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate dianion; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate(2-) · open the ingredient record
• Systematic review registration CRD42022212316 Registered protocol, no results here: Review Ongoing
  A systematic review of the potential role of abnormal vitamin B6 levels in patients with Parkinson's disease
  Condition or outcome area: Parkinson's disease
  2022-05-20 · Subject: Vitaminｂ · open the ingredient record
• Systematic review registration CRD42019146727 Registered protocol, no results here: Review Ongoing
  Homocysteine, vitamin B6, B12 and folic acid in patients with dementia, and vitamin B treatment effects on cognitive performance
  Condition or outcome area: Dementia is one of the most devastating chronic diseases in the elderly. It belongs to a group of conditions known as multiple degenerative encephalopathy, and is characterized by memory loss, cognitive dysfunction, and loss of self-care ability. Dementia has become a global problem, with about one in five people over the age of 75 suffering with the condition, and about 50 million people diagnosed worldwide, a figure which is expected to reach 75 million by 2030 (and which may even reach 132 mi
  2019-11-20 · Subject: Vitamin b6; Pyridoxal 5'-phosphate(2-); pyridoxal 5'-phosphate(2-); (4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl phosphate; 124051-94-1; pyridoxal 5'-phosphate dianion; CHEBI:597326; Q27225781; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate dianion; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate(2-) · open the ingredient record
• Systematic review registration CRD42019146727 Registered protocol, no results here: Review Ongoing
  Homocysteine, vitamin B6, B12 and folic acid in patients with dementia, and vitamin B treatment effects on cognitive performance
  Condition or outcome area: Dementia is one of the most devastating chronic diseases in the elderly. It belongs to a group of conditions known as multiple degenerative encephalopathy, and is characterized by memory loss, cognitive dysfunction, and loss of self-care ability. Dementia has become a global problem, with about one in five people over the age of 75 suffering with the condition, and about 50 million people diagnosed worldwide, a figure which is expected to reach 75 million by 2030 (and which may even reach 132 mi
  2019-11-20 · Subject: Vitamin b; Niacinamide; nicotinamide; niacinamide; 98-92-0; 3-Pyridinecarboxamide; pyridine-3-carboxamide; Nicotinic acid amide; vitamin PP; Aminicotin · open the ingredient record
• Systematic review registration CRD42019146727 Registered protocol, no results here: Review Ongoing
  Homocysteine, vitamin B6, B12 and folic acid in patients with dementia, and vitamin B treatment effects on cognitive performance
  Condition or outcome area: Dementia is one of the most devastating chronic diseases in the elderly. It belongs to a group of conditions known as multiple degenerative encephalopathy, and is characterized by memory loss, cognitive dysfunction, and loss of self-care ability. Dementia has become a global problem, with about one in five people over the age of 75 suffering with the condition, and about 50 million people diagnosed worldwide, a figure which is expected to reach 75 million by 2030 (and which may even reach 132 mi
  2019-11-20 · Subject: Vitaminｂ · open the ingredient record
• Systematic review registration CRD42018086540 Registered protocol, no results here: Review Ongoing
  Vitamin B6 and lung cancer risk: a systematic review and meta-analysis
  Condition or outcome area: Lung cancer. Vitamin B6 intake.
  2018-02-02 · Subject: Vitamin b6; Pyridoxal 5'-phosphate(2-); pyridoxal 5'-phosphate(2-); (4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl phosphate; 124051-94-1; pyridoxal 5'-phosphate dianion; CHEBI:597326; Q27225781; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate dianion; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate(2-) · open the ingredient record
• Systematic review registration CRD42018086540 Registered protocol, no results here: Review Ongoing
  Vitamin B6 and lung cancer risk: a systematic review and meta-analysis
  Condition or outcome area: Lung cancer. Vitamin B6 intake.
  2018-02-02 · Subject: Vitaminｂ · open the ingredient record
• Systematic review registration CRD42018086377 Registered protocol, no results here: Review Ongoing
  Disodium cantharidinate and vitamin B6 injection adjunct with platinum-based chemotherapy for the treatment of advanced non-small-cell lung cancer: a meta-analysis and systematic review
  Condition or outcome area: Non-small-cell lung cancer
  2018-01-25 · Subject: Vitamin b6; Pyridoxal 5'-phosphate(2-); pyridoxal 5'-phosphate(2-); (4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl phosphate; 124051-94-1; pyridoxal 5'-phosphate dianion; CHEBI:597326; Q27225781; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate dianion; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate(2-) · open the ingredient record
• Systematic review registration CRD42018086377 Registered protocol, no results here: Review Ongoing
  Disodium cantharidinate and vitamin B6 injection adjunct with platinum-based chemotherapy for the treatment of advanced non-small-cell lung cancer: a meta-analysis and systematic review
  Condition or outcome area: Non-small-cell lung cancer
  2018-01-25 · Subject: Vitaminｂ · open the ingredient record
• Systematic review registration CRD42022340121 Registered protocol, no results here: Review Ongoing
  Effectiveness of Urea-Based Cream and Pyridoxine(vitamin B6) on Sorafenib-induced Hand-foot Syndrome/skin reaction in hepatocellular carcinoma patients: A Systematic Review and Meta-analysis
  Condition or outcome area: Sorafenib is a multitargeted tyrosine kinase inhibitor, which has been mainly used in the treatment of advanced hepatocellular carcinoma. During the treatment, sorafenib can cause a variety of toxic reactions, such as hand-foot syndrome / skin reaction, hypertension, arterial thromboembolism, diarrhea and so on. Hand-foot Syndrome (HFS)/skin reaction(HFSR) is considered the most clinically significant dermatologic adverse event. For patients, these debilitating symptoms hinder their ability to
  2022-09-10 · Subject: Vitamin b6; Pyridoxal 5'-phosphate(2-); pyridoxal 5'-phosphate(2-); (4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl phosphate; 124051-94-1; pyridoxal 5'-phosphate dianion; CHEBI:597326; Q27225781; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate dianion; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate(2-) · open the ingredient record
• Systematic review registration CRD42022340121 Registered protocol, no results here: Review Ongoing
  Effectiveness of Urea-Based Cream and Pyridoxine(vitamin B6) on Sorafenib-induced Hand-foot Syndrome/skin reaction in hepatocellular carcinoma patients: A Systematic Review and Meta-analysis
  Condition or outcome area: Sorafenib is a multitargeted tyrosine kinase inhibitor, which has been mainly used in the treatment of advanced hepatocellular carcinoma. During the treatment, sorafenib can cause a variety of toxic reactions, such as hand-foot syndrome / skin reaction, hypertension, arterial thromboembolism, diarrhea and so on. Hand-foot Syndrome (HFS)/skin reaction(HFSR) is considered the most clinically significant dermatologic adverse event. For patients, these debilitating symptoms hinder their ability to
  2022-09-10 · Subject: Vitaminｂ１ · open the ingredient record
• Systematic review registration CRD42022340121 Registered protocol, no results here: Review Ongoing
  Effectiveness of Urea-Based Cream and Pyridoxine(vitamin B6) on Sorafenib-induced Hand-foot Syndrome/skin reaction in hepatocellular carcinoma patients: A Systematic Review and Meta-analysis
  Condition or outcome area: Sorafenib is a multitargeted tyrosine kinase inhibitor, which has been mainly used in the treatment of advanced hepatocellular carcinoma. During the treatment, sorafenib can cause a variety of toxic reactions, such as hand-foot syndrome / skin reaction, hypertension, arterial thromboembolism, diarrhea and so on. Hand-foot Syndrome (HFS)/skin reaction(HFSR) is considered the most clinically significant dermatologic adverse event. For patients, these debilitating symptoms hinder their ability to
  2022-09-10 · Subject: Vitaminｂ · open the ingredient record
• Systematic review registration CRD42022340121 Registered protocol, no results here: Review Ongoing
  Effectiveness of Urea-Based Cream and Pyridoxine(vitamin B6) on Sorafenib-induced Hand-foot Syndrome/skin reaction in hepatocellular carcinoma patients: A Systematic Review and Meta-analysis
  Condition or outcome area: Sorafenib is a multitargeted tyrosine kinase inhibitor, which has been mainly used in the treatment of advanced hepatocellular carcinoma. During the treatment, sorafenib can cause a variety of toxic reactions, such as hand-foot syndrome / skin reaction, hypertension, arterial thromboembolism, diarrhea and so on. Hand-foot Syndrome (HFS)/skin reaction(HFSR) is considered the most clinically significant dermatologic adverse event. For patients, these debilitating symptoms hinder their ability to
  2022-09-10 · Subject: Ur; Urea; urea; 57-13-6; carbamide; Isourea; Carbonyldiamide; Ureophil; Carbonyldiamine; Ureaphil · open the ingredient record
• Publication PMID 36355132 Research model: Cell Experiment
  Vitamin B6 Inhibits High Glucose-Induced Islet β Cell Apoptosis by Upregulating Autophagy
  Condition or outcome area: diabetes
  Metabolites · 2022 · Subject: Vitamin b6; Pyridoxal 5'-phosphate(2-); pyridoxal 5'-phosphate(2-); (4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl phosphate; 124051-94-1; pyridoxal 5'-phosphate dianion; CHEBI:597326; Q27225781; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate dianion; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate(2-) · open the ingredient record · DOI 10.3390/metabo12111048
• Publication PMID 33255657 Research model: Animal & Cell Experiment
  Rice Bran and Vitamin B6 Suppress Pathological Neovascularization in a Murine Model of Age-Related Macular Degeneration as Novel HIF Inhibitors
  Condition or outcome area: retinopathy of prematurity; age-related macular degeneration; blindness; retinal neovascularization; pathological retinal neovascularization; pathological ocular neovascularization; chorioretinal atrophy; Pathological neovascularization
  Int J Mol Sci · 2020 · Subject: Vitamin b6; Pyridoxal 5'-phosphate(2-); pyridoxal 5'-phosphate(2-); (4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl phosphate; 124051-94-1; pyridoxal 5'-phosphate dianion; CHEBI:597326; Q27225781; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate dianion; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate(2-) · open the ingredient record · DOI 10.3390/ijms21238940
• Publication PMID 32967056 Research model: Animal Experiment
  Vitamin B6 prevents excessive inflammation by reducing accumulation of sphingosine-1-phosphate in a sphingosine-1-phosphate lyase-dependent manner
  Condition or outcome area: endotoxic shock; attenuated experimental autoimmune encephalomyelitis; SPL deficiency
  J Cell Mol Med · 2020 · Subject: Vitamin b6; Pyridoxal 5'-phosphate(2-); pyridoxal 5'-phosphate(2-); (4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl phosphate; 124051-94-1; pyridoxal 5'-phosphate dianion; CHEBI:597326; Q27225781; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate dianion; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate(2-) · open the ingredient record · DOI 10.1111/jcmm.15917
• Publication PMID 31970902 Research model: Animal & Cell Experiment
  Vitamin B6 inhibits macrophage activation to prevent lipopolysaccharide-induced acute pneumonia in mice
  Condition or outcome area: pulmonary inflammation; systemic inflammation; acute pneumonia; acute pulmonary inflammation
  J Cell Mol Med · 2020 · Subject: Vitamin b6; Pyridoxal 5'-phosphate(2-); pyridoxal 5'-phosphate(2-); (4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl phosphate; 124051-94-1; pyridoxal 5'-phosphate dianion; CHEBI:597326; Q27225781; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate dianion; 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate(2-) · open the ingredient record · DOI 10.1111/jcmm.14983